Bangladesh - English - DGDA (Directorate General of Drug Administration)

global capsules ltd., gelatin division - gelatin - raw materials - 100%

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ranvet pty. limited - gelatin - unknown - gelatin filler active 0.0 - active constituent

Australia - English - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - succinylated gelatin, quantity: 40 g/l - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; water for injections - gelofusine is indicated as a collodial plasma volume substitute in: 1. treatment and prevention of hypovolaemia: absolute hypovolaemia from haemorrhage or other cases of intravascular fluid loss or perioperative intravascular fluid maintenance; and relative hypovolaemia secondary to induction of epidual or spinal anaesthesia, non-hypovolaemic shock. 2.hacmodilution (perioperative, therapeutic venesection). 3.extra-corporeal circulation (cardiac surgery, plasma exchange, haemodialysis).

Australia - English - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - succinylated gelatin, quantity: 40 g/l - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; water for injections - gelofusine is indicated as a collodial plasma volume substitute in:treatment and prevention of hypovolaemia: absolute hypovolaemia from haemorrhage or other cases of intravascular fluid loss or perioperative intravascular fluid maintenance; and relative hypovolaemia secondary to induction of epidural or spinal anaesthesia, non-hypovolaemic shock. 2.haemodilution (perioperative, therapeutic venesection); 3.extra-corporeal circulation (cardiac surgery, plasma exchange, haemodialysis).

Australia - English - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - succinylated gelatin, quantity: 40 g/l - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; water for injections - gelofusine is indicated as a colloidal plasma volume substitute in: 1. treatment and prevention of hypovolaemia: absolute hypovolaemia from haemorrhage or other cases of intravascular fluid loss or perioperative intravascular fluid maintenance; and relative hypovolaemia secondary to induction of epidural or spinal anaesthesia,non-hypovolaemic shock. 2. haemodilution (perioperative, therapeutic venesection); 3. extra-corporeal circulation (cardiac surgery, plasma exchange, haemodialysis).

Ireland - English - HPRA (Health Products Regulatory Authority)

b. braun melsungen ag - succinylated gelatine (= modified fluid gelatine); sodium chloride; sodium hydroxide - solution for infusion - 40 milligram(s)/millilitre - blood substitutes and plasma protein fractions; gelatin agents

Ireland - English - HPRA (Health Products Regulatory Authority)

b. braun melsungen ag - succinylated gelatine (= modified fluid gelatine); sodium chloride; sodium acetate trihydrate ; potassium chloride; calcium chloride dihydrate; magnesium chloride hexahydrate - solution for infusion - 4 percent - blood substitutes and plasma protein fractions; gelatin agents

Australia - English - Department of Health (Therapeutic Goods Administration)

nova pharmaceuticals australasia pty ltd - paracetamol, quantity: 500 mg - tablet, gelatin coated - excipient ingredients: sorbitol solution (70 per cent) (non-crystallising); isopropyl alcohol; titanium dioxide; gelatin; light liquid paraffin; purified water; sodium starch glycollate; magnesium stearate; pregelatinised maize starch; brilliant blue fcf; povidone; maize starch; glycerol; hypromellose; purified talc; macrogol 6000 - temporary relief of pain and discomfort associated with headache, migraine headache, tension headache, sinus pain, toothache, dental procedures, backache, muscular aches and pains, arthritis, osteoarthritis, rheumatic pain, period pain, fibrositis, neuralgia, sore throat, tennis elbow, and colds and flu. reduces fever.

Australia - English - Department of Health (Therapeutic Goods Administration)

orion laboratories pty ltd t/a perrigo australia - ibuprofen, quantity: 200 mg - tablet, gelatin coated - excipient ingredients: colloidal anhydrous silica; magnesium stearate; hypromellose; titanium dioxide; allura red ac; microcrystalline cellulose; sodium lauryl sulfate; brilliant blue fcf; gelatin; sodium starch glycollate type a - for the temporary relief of pain (and discomfort) associated with headache, migraine headache, tension headache, sinus pain, toothache, dental procedures, backache, muscular aches and pains, period pain, sore throat, tennis elbow, arthritis, rheumatic pain and the aches and pains associated with colds and flu. reduces fever.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrow pharma pty ltd - paracetamol, quantity: 498.9288 mg - tablet, gelatin coated - excipient ingredients: pregelatinised maize starch; titanium dioxide; hypromellose; allura red ac; gelatin; sodium lauryl sulfate; stearic acid; povidone - for the temporary relief of pain and fever.